Antibiotics work by targeting features that bacteria have and human cells don’t, or by locking onto bacterial versions of shared machinery that look different from ours.

Big idea: selective targeting

Antibiotics are designed to be selective , meaning they harm bacteria much more than they harm your own cells.

They do this by attacking structures or processes that are unique to bacteria (like their cell wall) or by binding to bacterial enzymes and ribosomes that are shaped differently from human ones.

Key targets antibiotics use

Here are the main “weak spots” in bacteria that antibiotics go after:

  1. Bacterial cell wall (humans don’t have this)
    • Most bacteria are wrapped in a rigid cell wall made of peptidoglycan, a mesh-like molecule that human cells simply do not make.
 * Penicillin and related drugs block the final cross-linking step needed to build this wall, causing the wall to weaken and the bacterium to burst from internal pressure.

 * Because human cells lack peptidoglycan and cell walls entirely, this step doesn’t exist in us, so the drug has nothing to attack in our cells.
  1. Folate synthesis pathway (bacteria must make their own)
    • All cells need folic acid, but human cells take folate in from the diet, while many bacteria must synthesize it from scratch.
 * Sulfonamide antibiotics mimic a natural bacterial molecule (para‑aminobenzoic acid), blocking a bacterial enzyme called dihydropteroate synthase, and thereby shutting down folate production and bacterial growth.

 * Our cells don’t use that enzyme or that synthetic pathway, so this block doesn’t hit human cells the same way.
  1. Bacterial ribosomes (protein factories with different shapes)
    • Both humans and bacteria make proteins on ribosomes, but bacterial ribosomes have 30S and 50S subunits, while human cytoplasmic ribosomes have 40S and 60S subunits.
 * Drugs like tetracyclines and some other antibiotics bind specifically to bacterial ribosomal subunits (often the 30S), blocking the addition of new amino acids to growing proteins.

 * The shape differences mean these drugs don’t fit well onto human ribosomes, so our protein synthesis is largely spared at normal doses.
  1. Bacterial DNA replication enzymes
    • Bacteria need special enzymes (like DNA gyrase and certain topoisomerases) to unwind and manage their circular DNA so it can be copied.
 * Fluoroquinolone antibiotics (such as ciprofloxacin) bind to bacterial DNA gyrase and related enzymes, blocking DNA replication and killing the bacteria.

 * Human cells have analogous enzymes, but their structure is different enough that these antibiotics bind primarily to the bacterial versions.

Quick HTML table: main mechanisms

html

<table>
  <tr>
    <th>Antibiotic target</th>
    <th>What it does to bacteria</th>
    <th>Why human cells are mostly spared</th>
  </tr>
  <tr>
    <td>Peptidoglycan cell wall (e.g., penicillin)</td>
    <td>Blocks wall cross-linking, wall weakens and cell bursts [web:1]</td>
    <td>Human cells have no peptidoglycan or cell wall [web:1]</td>
  </tr>
  <tr>
    <td>Folate synthesis (sulfonamides)</td>
    <td>Inhibits folate-producing enzyme, stops growth [web:1]</td>
    <td>Humans import folate from diet; pathway not used [web:1]</td>
  </tr>
  <tr>
    <td>Bacterial ribosomes (tetracyclines and others)</td>
    <td>Bind 30S/50S subunits, block protein synthesis [web:1][web:7]</td>
    <td>Human ribosomes are structurally different (40S/60S) [web:7]</td>
  </tr>
  <tr>
    <td>DNA gyrase/topoisomerase (fluoroquinolones)</td>
    <td>Block DNA unwinding and replication [web:1][web:5]</td>
    <td>Human enzymes differ, so binding is much weaker [web:1][web:5]</td>
  </tr>
</table>

So why do side effects happen?

Even though antibiotics are designed to be selective, they’re not perfect.

Some can still interact weakly with similar machinery in human cells or in mitochondria (the energy-producing structures that evolved from bacteria), which can contribute to side effects at higher doses or with prolonged use.

They also disturb helpful bacteria in your gut and on your skin, which can cause issues like diarrhea or yeast overgrowth even if your human cells themselves are not directly damaged.

Putting it simply

  • Antibiotics work because bacterial cells have unique “handles” (like a peptidoglycan wall and special enzymes) that human cells lack.
  • When bacteria and humans share a process (like protein or DNA synthesis), antibiotics often latch onto the bacterial version of the machinery more tightly due to structural differences.
  • This combination of unique targets and shape differences is what lets antibiotics kill or stop bacteria while mostly sparing the surrounding human cells.

TL;DR: Antibiotics don’t magically “ignore” human cells—they are engineered to lock onto molecules and machines that are either only present in bacteria or structurally different enough that the drug fits bacteria much better than it fits us.